Inma Mora

Dr. Inma Mora

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JSJorge Soriano
Jorge Soriano
IMInma Mora
Inma Mora
MAM. E. Alea-Reyes
M. E. Alea-Reyes
LPLluisa Perez-Garcia
Lluisa Perez-Garcia
LBLleonard Barrios
Lleonard Barrios
CNCarme Nogués
Carme Nogués
Cell death triggered by photodynamic therapy can occur through different mechanisms: apoptosis, necrosis or autophagy. However, recent studies have demonstrated the existence of other mechanisms with characteristics of both necrosis and apoptosis. These new cell death pathways, collectively termed regulated necrosis, include a variety of processes triggered by different stimuli. In this study, we evaluated the cell death mechanism induced by photodynamic treatments with two photosensitizers, meso-tetrakis (4-carboxyphenyl) porphyrin sodium salt (Na-H2TCPP) and its zinc derivative Na-ZnTCPP, in two human breast epithelial cell lines, a non-tumoral (MCF-10A) and a tumoral one (SKBR-3). Viability assays showed that photodynamic treatments with both photosensitizers induced a reduction in cell viability in a concentration-dependent manner and no dark toxicity was observed. The cell death mechanisms triggered were evaluated by several assays and cell line-dependent results were found. Most SKBR-3 cells died by either necrosis or apoptosis. By contrast, in MCF-10A cells, necrotic cells and another cell population with characteristics of both necrosis and apoptosis were predominant. In this latter population, cell death was PARP-dependent and translocation of AIF to the nucleus was observed in some cells. These characteristics are related with parthanatos, being the first evidence of this type of regulated necrosis in the field of photodynamic therapy.

1 October 2017 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
MAMaría E. Alea-Reyes
María E. Alea-Reyes
JSJorge Soriano
Jorge Soriano
IMInma Mora
Inma Mora
MRMafalda Rodrigues
Mafalda Rodrigues
DRDavid A. Russell
David A. Russell
LPLluisa Perez-Garcia
Lluisa Perez-Garcia

4 December 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IMInma Mora
Inma Mora
LBLleonard Barrios
Lleonard Barrios
EIElena Ibáñez
Elena Ibáñez
JSJorge Soriano
Jorge Soriano
CNCarme Nogués
Carme Nogués
Therapeutic drug carriers can drive their cargo to their target cells. However, an obstacle is usually the entrapment of the drug inside the endolysosomal compartment, which physically impedes its actuation by the impossibility of reaching its molecular site of action. To overcome this hurdle, photochemical internalization (PCI) has been proposed, but the extent of PCI-induced membrane disruption and its capability to allow the release of microparticles is unknown. The aim of the present study was to determine if PCI allows the release of microparticles from the endolysosomal compartment to the cytosol and to analyze at the ultrastructural level the effect of PCI on the membrane surrounding the particles. Confocal microscope allowed us to detect that endolysosomal membranes suffered some disruption after PCI, evidenced by the diffusion of soluble transferrin from the endolysosomes to the cytosol and by a decrease of LAMP1-microparticles co-localization. Transmission electron microscopy (TEM) showed a decrease in the number of well-defined membranes around microparticles after PCI, and scanning TEM combined with energy dispersive x-ray revealed an increase in the width of endolysosomal membranes after treatment. These results suggest that endolysosomal membranes suffered an ultrastructure alteration after PCI, enough to liberate soluble transferrin but not the entire microparticles.

1 August 2015 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
SNSergi Novo
Sergi Novo
IMInma Mora
Inma Mora
RGRodrigo Gómez-Martínez
Rodrigo Gómez-Martínez
LBLleonard Barrios
Lleonard Barrios
EIElena Ibáñez
Elena Ibáñez
CNCarme Nogués
Carme Nogués

11 April 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
IMInma Mora
Inma Mora
EIElena Ibáñez
Elena Ibáñez
JSJorge Soriano
Jorge Soriano
CNCarme Nogués
Carme Nogués
Thorarinn GudjonssonThorarinn Gudjonsson
Thorarinn Gudjonsson
LBLleonard Barrios
Lleonard Barrios
Purpose: To determine if the specific targeting of microparticles improves their internalization by cells under fluidic conditions. Methods: Two isogenic breast epithelial cell lines, one overexpressing the Human Epidermal Growth Factor Receptor 2 (HER2) oncogene (D492HER2) and highly tumorigenic and the other expressing HER2 at much lower levels and non-tumorigenic (D492), were cultured in the presence of polystyrene microparticles of 1 µm in diameter, biofunctionalized with either a specific anti-HER2 antibody or a non-specific secondary antibody. Mono- and cocultures of both cell lines in static and fluidic conditions were performed, and the cells with internalized microparticles were scored. Results: Globally, the D492 cell line showed a higher endocytic capacity than the D492HER2 cell line. Microparticles that were functionalized with the anti-HER2 antibody were internalized by a higher percentage of cells than microparticles functionalized with the non-specific secondary antibody. Although internalization was reduced in fluidic culture conditions in comparison with static conditions, the increase in the internalization of microparticles biofunctionalized with the anti-HER2 antibody was higher for the cell line overexpressing HER2. Conclusion: The biofunctionalization of microparticles with a specific targeting molecule remarkably increases their internalization by cells in fluidic culture conditions (simulating the blood stream). This result emphasizes the importance of targeting for future in vivo delivery of drugs and bioactive molecules through microparticles.